Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry

Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast...

Full description

Bibliographic Details
Main Authors: N. Poulin, A. Frost, A. Carraro, E. Mommers, M. Guillaud, P.J. van Diest, W. Grizzle, S. Beenken
Format: Article
Language:English
Published: Hindawi Limited 2003-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2003/262918
id doaj-ba5e2e9c77794223b4c8cc0e3977a0c7
record_format Article
spelling doaj-ba5e2e9c77794223b4c8cc0e3977a0c72020-11-25T00:07:55ZengHindawi LimitedAnalytical Cellular Pathology0921-89121878-36512003-01-0125312913810.1155/2003/262918Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear MorphometryN. Poulin0A. Frost1A. Carraro2E. Mommers3M. Guillaud4P.J. van Diest5W. Grizzle6S. Beenken7Cancer Imaging, BC Cancer Research Center, Vancouver, CanadaDepartments of Surgery and Pathology, University of Alabama at Birmingham, UKCancer Imaging, BC Cancer Research Center, Vancouver, CanadaInstitute for Pathology, Free University of Amsterdam, The NetherlandsCancer Imaging, BC Cancer Research Center, Vancouver, CanadaInstitute for Pathology, Free University of Amsterdam, The NetherlandsDepartments of Surgery and Pathology, University of Alabama at Birmingham, UKDepartments of Surgery and Pathology, University of Alabama at Birmingham, UKNuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast neoplasia. Nuclear features are derived from computerized analysis of digitized microscope images, and a quantitative Feulgen stain for DNA was used. Features analyzed included: (1) DNA content; (2) nuclear size and shape; and (3) texture features, describing spatial features of chromatin distribution. In this study replicated measurements are described on a series of 54 breast carcinoma specimens of differing pathologic grades. Duplicate measurements were performed using two serial sections, which were processed and analyzed separately. The value of a single feature measurement, the nuclear area profile, was shown to be the strongest indicator of progression. A quantitative nuclear grade was derived and shown to be strongly correlated with not only the pathologic nuclear grade, but also with tubule formation, mitotic grade, and with the overall histopathologic grade. Analysis of replication precision showed that the standard methods of the histopathology laboratory, if practiced in a uniform manner, are sufficient to ensure reproducibility of these assessments. We argue that nuclear morphometry provides a standardized and reproducible framework for quantitative pathologic assessments.http://dx.doi.org/10.1155/2003/262918
collection DOAJ
language English
format Article
sources DOAJ
author N. Poulin
A. Frost
A. Carraro
E. Mommers
M. Guillaud
P.J. van Diest
W. Grizzle
S. Beenken
spellingShingle N. Poulin
A. Frost
A. Carraro
E. Mommers
M. Guillaud
P.J. van Diest
W. Grizzle
S. Beenken
Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
Analytical Cellular Pathology
author_facet N. Poulin
A. Frost
A. Carraro
E. Mommers
M. Guillaud
P.J. van Diest
W. Grizzle
S. Beenken
author_sort N. Poulin
title Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_short Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_full Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_fullStr Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_full_unstemmed Risk Biomarker Assessment for Breast Cancer Progression: Replication Precision of Nuclear Morphometry
title_sort risk biomarker assessment for breast cancer progression: replication precision of nuclear morphometry
publisher Hindawi Limited
series Analytical Cellular Pathology
issn 0921-8912
1878-3651
publishDate 2003-01-01
description Nuclear morphometry is a method for quantitative measurement of histopathologic changes in the appearance of stained cell nuclei. Numerous studies have indicated that these assessments may provide clinically relevant information related to the degree of progression and malignant potential of breast neoplasia. Nuclear features are derived from computerized analysis of digitized microscope images, and a quantitative Feulgen stain for DNA was used. Features analyzed included: (1) DNA content; (2) nuclear size and shape; and (3) texture features, describing spatial features of chromatin distribution. In this study replicated measurements are described on a series of 54 breast carcinoma specimens of differing pathologic grades. Duplicate measurements were performed using two serial sections, which were processed and analyzed separately. The value of a single feature measurement, the nuclear area profile, was shown to be the strongest indicator of progression. A quantitative nuclear grade was derived and shown to be strongly correlated with not only the pathologic nuclear grade, but also with tubule formation, mitotic grade, and with the overall histopathologic grade. Analysis of replication precision showed that the standard methods of the histopathology laboratory, if practiced in a uniform manner, are sufficient to ensure reproducibility of these assessments. We argue that nuclear morphometry provides a standardized and reproducible framework for quantitative pathologic assessments.
url http://dx.doi.org/10.1155/2003/262918
work_keys_str_mv AT npoulin riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT afrost riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT acarraro riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT emommers riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT mguillaud riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT pjvandiest riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT wgrizzle riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
AT sbeenken riskbiomarkerassessmentforbreastcancerprogressionreplicationprecisionofnuclearmorphometry
_version_ 1725417717497856000